This article is more than 5 years old. Information may no longer be current.
NuVasive launches expandable spinal interbody implant for TLIF
Click Here to Manage Email Alerts
NuVasive Inc. announced the launch of the TLX 20° expandable spinal interbody implant with the first-of-its-kind oblique profile intended for transforaminal lumbar interbody fusion, according to a company press release.
The implant has an auto-lock feature that lets surgeons customize expansion incrementally up to 20° of oblique lordosis and tailor implant expansion based on a patient’s clinical need.The implant profile reportedly contours to a patient’s interdiscal space to maintain coronal alignment and achieve sagittal correction. The TLX 20° expandable implant also includes a single, low-profile instrument to position, expand and post-pack the implant with bone graft. This reportedly improves visualization into the disc space and surgical workflow. It also has increased tapering at the distal tip to help with insertion into the collapsed disc space.
“The innovative, oblique profile of the TLX 20° expandable implant is a true differentiator in the expandable interbody market,” Matt Link, executive vice president of strategy, technology and corporate development of NuVasive, said in the release. “With this latest addition, NuVasive continues to offer our surgeon partner's the most innovative procedurally integrated portfolio in spine to further their treatment options for patients of varying sizes and clinical needs.”
Reference: